22:55 , Oct 30, 2018 |  BC Extra  |  Company News

Management tracks: Blueprint, Clovis

Ahead of the anticipated 2019 launch of avapritinib, Blueprint Medicines Corp. (NASDAQ:BPMC) hired Christina Rossi into the newly created role of chief commercial officer. She was the multiple sclerosis business unit head of North America...
08:00 , Jan 7, 2013 |  BioCentury  |  Product Development

Divergent DMF paths

Forward Pharma A/S has taken a different path to improve the safety and efficacy of fumarate than has Biogen Idec Inc. While Biogen's BG-12 is under review for multiple sclerosis, Forward has set its sights...
07:00 , Jun 16, 2008 |  BC Week In Review  |  Company News

Orexo management update

Orexo AB (SSE:ORX), Uppsala, Sweden   Business: Drug delivery, Infectious, Neurology   Hired: Robin Wright as head of business and commercial development, formerly head of corporate advisory services at BioScience Managers Ltd; he replaces Goran...
07:00 , Jun 9, 2008 |  BC Week In Review  |  Company News

Topigen board of directors update

Topigen Pharmaceuticals Inc. , Montreal, Quebec   Business: Inflammation, Autoimmune   Appointed: Jeremy Curnock Cook, executive chairman and founder of BioScience Managers Ltd.  ...
07:00 , Apr 28, 2008 |  BC Week In Review  |  Company News

Aegera board of directors update

Aegera Therapeutics Inc. Montreal, Quebec   Business: Neurology, Cancer   Appointed: Jeremy Cook, executive chairman and founder of BioScience Managers Ltd.; and Gary Littlejohn, managing director of Desjardins Securities Inc.  ...
07:00 , Mar 24, 2008 |  BioCentury  |  Finance

Ebb & Flow

Amgen has shed $61 billion, or 58% of its market cap, over the last three and a half years and last week found itself slipping into third place among top tier biotechs, giving up the...
08:00 , Nov 20, 2006 |  BC Week In Review  |  Company News

Osteologix board of directors update

Osteologix Inc. (OLGX), San Francisco, Calif.   Business: Musculoskeletal   Appointed: Jeremy Curnock Cook, executive chairman of Bioscience Managers Ltd.  ...
07:00 , Sep 18, 2006 |  BC Week In Review  |  Company News

Inflazyme board of directors update

Inflazyme Pharmaceuticals Ltd. (TSE: IZP), Vancouver, B.C.   Business: Inflammation   Appointed: Jeremy Curnock Cook, executive chairman at Bioscience Managers Ltd., as chairman; he replaces John Hodgman, who resigned  ...
07:00 , Jun 26, 2006 |  BC Week In Review  |  Company News

Bioscience Managers Ltd., Nordic Biotech K/S deal

BioScience Managers acquired part of Nordic Biotech’s stake in certain portfolio companies. The portfolio companies include neurology and infectious disease company LifeCycle Pharma A/S (Horsholm, Denmark); allergy play CuraLogic A/S (CSE:CUR, Copenhagen, Denmark); dermatology company...
07:00 , Jun 26, 2006 |  BioCentury  |  Finance

Ebb & Flow

Speculators start your engines. Last week saw developments in the insomnia space that have analysts and investors pondering the futures of Sepracor (SEPR) and Neurocrine (NBIX). SEPR started the week with a 9% pop on...